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Arginase I and Polyamines Act Downstream
from Cyclic AMP in Overcoming Inhibition of
Axonal Growth MAG and Myelin In Vitro
In contrast to the mature CNS, many young neurons
do regenerate in vivo (Bates and Stelzner, 1993; Breg-
man and Goldberger, 1983) and are not inhibited by
MAG (DeBellard et al., 1996). Their growth is promoted
by MAG, and they can extend long neurites when grown
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promotion to inhibition by MAG and myelin often coin-77 Avenue Louis Pasteur
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in vivo (Cai et al., 2001). Therefore, the response of a
neuron to MAG and myelin in culture is a strong indicator
of its capacity to regenerate in vivo.Summary
Recently, we showed that elevating neuronal cAMP,
either with a cAMP analog or by exposure to variousElevation of cAMP can overcome myelin inhibitors to
neurotrophins (NT), overcomes inhibition by MAG andencourage regeneration of the CNS. We show that a
myelin (Cai et al., 1999). Importantly, elevated cAMP inconsequence of elevated cAMP is the synthesis of
vivo results in regeneration of mature spinal axons (Qiupolyamines, resulting from an up-regulation of Argi-
et al., 2002; Neumann et al., 2002) and plays a role innase I, a key enzyme in their synthesis. Inhibiting
the spontaneous regeneration of neonatal spinal cordpolyamine synthesis blocks the cAMP effect on regen-
axons after injury (Cai et al., 2001). The downstreameration. Either over-expression of Arginase I or exoge-
consequences of elevated cAMP and activation of pro-nous polyamines can overcome inhibition by MAG and
tein kinase A (PKA), a cAMP effector that results in re-by myelin in general. While MAG/myelin support the
generation on myelin and in vivo, are not known. It isgrowth of young DRG neurons, they become inhibitory
possible that PKA affects axonal growth through a directas DRGs mature. Endogenous Arginase I levels are
action on cytoskeletal behavior or indirectly by initiatinghigh in young DRGs but drop spontaneously at an
transcription of specific genes.age that coincides with the switch from promotion to
One candidate gene that is known to be upregulatedinhibition by MAG/myelin. Over-expressing Arginase
in response to cAMP in liver (Nebes and Morris, 1988)
I in maturing DRGs blocks that switch. Arginase I and
and macrophages (Morris et al., 1998) is the gene for
polyamines are more specific targets than cAMP for
Arginase I (Arg I), an enzyme shown to have an anti-
intervention to encourage regeneration after CNS apoptotic effect in neurons (Esch et al., 1998). Arginase
injury. exists in two distinct isoforms, one cytosolic (Arg I) and
the second mitochondrial (Arg II) (Nakamura et al., 1990).
Introduction Both catalyze the hydrolysis of arginine to ornithine and
urea. Ornithine is then converted in the cytosol to the
After injury, the adult CNS shows little spontaneous re- polyamine putrescine by the action of ornithine decar-
generation (Schwab and Bartholdi, 1996). Inhibitors of boxylase (ODC); putrescine is converted to two other
regeneration present in myelin are major obstacles to polyamines, spermidine and spermine (Seiler, 2000).
axonal regeneration, particularly immediately after injury Many studies have shown that polyamines influence
(Carbonetto et al., 1987; Caroni and Schwab, 1988; Huang growth and development of the nervous system (Slotkin
et al., 1999). To date, three inhibitors in myelin have and Bartolome, 1986; Slotkin et al., 1982) as well as
been identified: Nogo, an antigen of the IN-1 antibody axonal regeneration in systems that exhibit spontane-
(Chen et al., 2000; GrandPre et al., 2000; Prinjha et al., ous regrowth after injury (Gilad and Gilad, 1988; Gilad
2000), myelin-associated glycoprotein (MAG) (McKer- et al., 1996; Ingoglia et al., 1982).
racher et al., 1994; Mukhopadhyay et al., 1994), and Until now, a role for Arg I and its upregulation by cAMP
recently, myelin-oligodendrocyte glycoprotein (OMgp) in the nervous system has never been shown. Here, we
(Wang et al., 2002). Interestingly, to exert inhibition, all demonstrate that a transcription-dependent up-regula-
tion of Arg I accompanies the loss of inhibition by MAGthree of these proteins interact with the same receptor,
and myelin from elevated neuronal cAMP, either via dbinitially identified as the Nogo receptor (NgR) (Domeni-
cAMP or the neurotrophin BDNF (brain-derived nerveconi et al., 2002, Liu et al., 2002; Wang et al., 2002).
growth factor). We also show that direct inhibition of
polyamine synthesis blocks the ability of both db cAMP4 Correspondence: filbin@genectr.hunter.cuny.edu
and BDNF to overcome inhibition. Furthermore, overex-5 Present address: Laboratory of Molecular and Cellular Neurosci-
pression of Arg I and exogenous polyamines are eachence, The Rockefeller University, 1230 York Avenue, New York, New
York 10021. individually sufficient to overcome inhibition by MAG
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added either directly to the cultures when db cAMP is
added or during priming with BDNF, the ability of either
of these treatments to block inhibition is completely
abrogated. That is to say, inhibition by MAG is the same
as when no db cAMP or BDNF are added to the cultures.
DRB has no effect on growth on control cells. Further-
more, Figure 2 shows that the ability of db cAMP and
priming with BDNF to block inhibition of neurite out-
growth from cerebellar neurons on myelin is also tran-
scription-dependent. On myelin, in the presence of db
cAMP or after priming with BDNF, neurites are more
than twice as long, but this improved growth is lost if
DRB is included in the cultures. Therefore, the ability of
elevated cAMP in neurons (either with db cAMP or by
priming with BDNF) to block inhibition both by MAG
and by myelin in general is transcription-dependent. It
follows, then, that some gene(s) must be transcribed
and protein(s) synthesized in response to elevated
cAMP that are responsible for overcoming the inhibition
by MAG/myelin.Figure 1. The Ability of db cAMP and BDNF to Overcome Inhibition
by MAG Is Transcription Dependent
The Enzyme Arginase I Is Upregulated and PolyamineCerebellar neurons (P5) were isolated and either added directly to
Synthesis Increases in Neurons in ResponseMAG-expressing CHO cells (stripped bars) or control CHO cells
(black bars) in the presence of db cAMP (1 mM), with and without to Either db cAMP or BDNF
DRB (5 M) as indicated (A) or after being primed overnight with Recently, Arg I was shown to be one of the rate-limiting
BDNF (200 ng/ml) (B) after which they were cultured overnight, fixed, enzymes in the synthesis of polyamines (Kepka-Lenhart
and immunostained for GAP43. In each experiment, the mean length
et al., 2000) (Li et al., 2001). Furthermore, previous stud-of the longest GAP43-positive neurite for 180–200 neurons was
ies implicated polyamines in affecting axonal growth,measured ( SEM) for at least four separate experiments.
both in culture (Abe et al., 1997; Chu et al., 1995), and
in vivo (Dornay et al., 1986; Kauppila, 1992). Arg I is a
cytosolic enzyme, which in liver and in macrophages itand myelin. Finally, young neurons that grow well on
MAG and myelin also show high levels of Arg I while in is upregulated in response to elevated cAMP (Morris et
al., 1998; Nebes and Morris, 1988). To determine if Argolder neurons, growth is inhibited by MAG and myelin,
and Arg I levels have spontaneously decreased. Inhib- I is upregulated in neurons when cAMP is elevated,
cerebellar neurons were treated for various times withiting ODC blocks the growth of young neurons on MAG
and myelin, and overexpressing Arg I in older neurons either db cAMP or BDNF and (1) the RNA was extracted
and subjected to RT-PCR using primers specific for Argabolishes their growth inhibition by MAG and myelin.
I, or (2) the proteins were extracted, subjected to PAGE,
and transferred to membranes that were then stainedResults
with an Arg I antibody (Esch et al., 1998). Figure 3A
shows that there is a basal level of expression of Arg IBlocking Inhibition by MAG/Myelin with db cAMP
or Priming with Neurotrophins RNA in cerebellar neurons. When the neurons are
treated with either db cAMP or BDNF before extractionIs Transcription Dependent
Previously, we established that inhibition of axonal re- of RNA, Arg I mRNA increases by at least 2-fold but
never reaches the high levels found in liver (Figure 3A).generation by MAG and myelin was blocked by elevating
neuronal cAMP, either with the cAMP analog dibutyryl Importantly, after treatment with either BDNF or db
cAMP expression of Arg I, protein is increased by aboutcAMP (db cAMP) or by exposing the neurons to various
neurotrophins (NT) prior to when they are cultured on 5-fold (Figure 3B). By 3 hr after treatment with either
BDNF or db cAMP, the expression of Arg I protein, hasMAG or myelin (priming with NT) (Cai et al., 2001). Next
we wanted to determine if the ability to block inhibition reached maximum levels, which is sustained for at least
21 hr. By 24 hr, the level of expression has decreasedby MAG and myelin either with db cAMP or priming with
NT is dependent on transcription. slightly. The increase in Arg I expression is not due to
a loading difference on the gel because the antibodyFigure 1 shows that as reported before, neurite out-
growth from postnatal cerebellar neurons is inhibited by used stains another protein of about 60 kDa nonspecifi-
cally, and the staining of this protein is unaffected byabout 70% when grown on MAG-expressing CHO cells
compared to control CHO cells not expressing MAG. treatment with either db cAMP or BDNF (Figure 3B).
Therefore, the increase in expression of Arg I protein inEither addition of db cAMP directly to the cocultures or
priming the neurons with the neurotrophin, brain- response to elevation of cAMP in neurons is specific.
To assess if polyamine synthesis is increased in neu-derived neurotrophic factor (BDNF) blocks this inhibi-
tion. Neither of these treatments has any effect on neu- rons as a consequence of upregulation of Arg I by cAMP,
levels of putrescine, spermidine, and spermine wererite outgrowth on control cells (Figures 1A and 1B).
However, when an inhibitor of transcription, 5,6-di- measured after treatment with db cAMP or BDNF. Figure
4 shows that at both 6 and 18 hr after treatment withchloro-1-b-D-ribo-furanosyl-benzimidazole (DRB), is
Arg I, Polyamines in Regeneration on Myelin
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Figure 2. The Ability of db cAMP and BDNF
to Overcome Inhibition by Myelin Is Tran-
scription Dependent
Cerebellar neurons (P5) were isolated and ei-
ther added directly to a substrate of myelin
in the presence of db cAMP (1 mM) with and
without DRB (5 M) as indicated (A and B),
or after being primed overnight with BDNF
(200 ng/ml) (C), after which they were fixed
and immunostained for GAP43. In each ex-
periment, the mean length of the longest
GAP43-positive neurite for 180–200 neurons
was measured ( SEM) for at least four sepa-
rate experiments.
db cAMP, the putrescine levels have increased by about by MAG/myelin, cerebellar neurons were infected with
replication-incompetent adenoviral constructs con-2-fold. For cerebellar neurons treated with BDNF, pu-
trescine levels have doubled by 6 hr, and although still taining the cDNA for Arg I. These viral constructs also
contained the cDNA for green fluorescent protein (GFP).significantly elevated at 18 hr, are slightly decreased.
Spermine and spermidine are also increased in response Cerebellar neurons were isolated, plated onto poly
L-lysine and infected with viral constructs, and culturedto elevated cAMP, but levels of these polyamines are
higher at 18 hr than at 6 hr posttreatment (results not overnight to allow expression of the transgene. Figure
5A is a Western showing expression of Arg I in culturesshown). This is consistent with spermidine and spermine
being synthesized downstream of putrescine. infected with either the Arg I cDNA-containing virus or
control virus without Arg I cDNA. As can be seen when
the Arg I cDNA-containing virus is used, there is anOverexpression of Arginase I Is Sufficient to Block
Inhibition by MAG and Myelin abundance of Arg I protein expression 24 hr after infec-
tion, while under these same conditions, expression ofTo determine if the upregulation of Arg I in response to
cAMP is sufficient to overcome inhibition of regeneration endogenous Arg I is undetectable in the control-infected
neurons (Figure 5A). After culture for 24 hr, the infected
cells were then transferred onto MAG-expressing CHO
cells, control CHO cells, or myelin and cultured for 18–24
hr further before being fixed, stained, and neurite length
measured. For these cerebellar neurons, the rate of in-
fection is about 25%. Therefore, to ensure that only
those neurons infected with virus were included in the
analysis, only neurites from those neurons that were
both GAP43 positive and GFP positive were measured
Figure 3. Arg I Is Upregulated in Cerebellar Neurons in Response
to BDNF or db cAMP
Cerebellar neurons (P5) were plated onto poly L-lysine and cultured
for various times, as indicated, with either BDNF (200 ng/ml) or db
cAMP (1 mM).
(A) RNA was isolated, reverse transcribed, and subjected to RT PCR
using Arg-I-specific primers before being separated in an agarose
Figure 4. Synthesis of Putrescine Is Increased in Response to dbgel. Lane 1, RNA from liver; lane 2, RNA from untreated neurons;
cAMP or BDNFlane 3, neurons treated with BDNF for 18 hr; lane 4, neurons treated
with db cAMP for 18 hr. Cerebellar neurons (P5) were plated onto poly L-lysine and treated
with either db cAMP (1 mM), BDNF (200 ng/ml), or DFMO (1 mM) for(B) Western blot of lysates from neurons treated with BDNF (top)
or db cAMP (bottom) and immunostained with an Arg-I-specific various lengths of time as indicated and then lysed and putrescine
content measured by HPLC. Results are expressed as a percentageantibody. Each lane was loaded with 50 g of total protein. Times
of incubation are indicated across the top. Molecular weight markers of putrescine in untreated neurons  SEM. Each measurement was
carried out in triplicate, at least two times.are indicated on the left. The arrow indicates Arg I protein.
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which block the synthesis of polyamines. These two
inhibitors were each added separately, either directly to
the cocultures when db cAMP was used or during prim-
ing when BDNF was used. At a concentration of 1 mM,
either NOHA or DFMO completely blocked the ability of
db cAMP, or priming with BDNF, to overcome inhibition
of neurite outgrowth by MAG and myelin (Figures 6A–
6D). Neither inhibitor had an effect on growth on control
cells, on MAG-expressing cells, or on myelin (Figure 6).
This strongly suggests that synthesis of putrescine, and
possibly other polyamines, plays a role in the ability of
cAMP to overcome inhibition of MAG and myelin. To
test if this is the case, putrescine was included in the
cultures at the same time as NOHA or DFMO to deter-
mine if the improved growth induced by elevation of
cAMP could be restored. As shown in Figure 6, putres-
cine was able to overcome the DFMO and NOHA block
of the cAMP effect induced by either db cAMP or BDNF.
Priming with Polyamines Blocks Inhibition by MAG
and MyelinFigure 5. Overexpression of Arg I Is Sufficient to Overcome Inhibi-
tion by MAG and Myelin The question now raised is whether addition of poly-
Cerebellar neurons (P5) were isolated and infected with adenovirus amine alone is sufficient to block inhibition by MAG and
vectors containing the cDNA for Arg I and/or the cDNA for GFP. 24 myelin or whether an elevation of cAMP is also required
hr after infection, the neurons were either lysed and subjected to to activate another signaling pathway, apart from pu-
Western blotting or transferred to MAG-expressing CHO cells, con- trescine synthesis. To test this possibility, putrescine
trol CHO cells, or myelin before being fixed and stained for GAP 43
was added to cultures when the neurons were grownand viewed for GFP.
on MAG-expressing cells, control cells, and on myelin.(A) Western blot of neurons infected with Arg-I-cDNA-containing
virus (right lane) or with control virus (left lane). Numbers refer to As can be seen in Figure 7, addition of putrescine alone
position of the molecular weight markers. can indeed block the inhibition by both MAG and myelin
(B) Image of neurons positive for both GFP (left) and GAP43 (right). in a dose-dependent manner, with the maximum block
(C) Measurement of neurite length from neurons infected with con- of inhibition reached at a putrescine concentration of
trol virus (GFP) or with virus-containing Arg I cDNA (Arg I), grown
about 40 M. Putrescine alone had no effect on neuriteon either MAG-expressing CHO cells (stripped bars) or control CHO
outgrowth from neurons grown on control cells or oncells (black bars) before being fixed and stained for GAP43. In each
experiment, the mean length of the longest GAP43/GFP-positive poly L-lysine (results not shown). However, the block of
neurite for 180–200 neurons was measured ( SEM). Each experi- MAG’s inhibition was never complete as growth never
ment was carried out at least three times. reached that of neurons on the control CHO cells. The
maximum reversal of inhibition was to about 60% of
control. In contrast, if the neurons were primed with
(Figure 5B). It was found that infection of cerebellar putrescine overnight before being plated on the MAG
neurons with the control virus expressing only GFP had cells, inhibition was also blocked in a dose-dependent
no effect on the ability of MAG (Figure 5C) or myelin manner. But now, at 40 M, inhibition by MAG was
(data not shown) to inhibit neurite outgrowth. In contrast, completely blocked; growth was the same as on control
neurons infected with the Arg-I-cDNA-containing virus cells. Likewise, growth on myelin improved in a dose-
were not inhibited by MAG or myelin. Neurite outgrowth dependent manner and, at a concentration of 40 M,
in the Arg I-expressing neurons on MAG-expressing neurites were about twice as long if putrescine was
cells was the same as on the control CHO cells not added directly to the media without priming (Figure 7B).
expressing MAG. On myelin, neurite length was equiva- If instead the neurons were primed overnight with pu-
lent to neurites when the neurons were grown in the trescine before being cultured on myelin, neurites were
presence of db cAMP (20  2 m and 19  2.3 m, again longer, and the effect was dose-dependent. How-
respectively). These results suggest that upregulation ever, after priming at 40 M putrescine, neurites were
of Arg I alone, in the absence of elevation of cAMP, is now more than four times longer than from neurons
sufficient to overcome inhibition of axonal growth by primed without putrescine (Figure 7B). The effect of
MAG and myelin. priming with 40 M putrescine on neurite outgrowth on
myelin is even greater than that observed when db cAMP
is added directly to the media or the neurons wereInhibitors of Polyamine Synthesis Block the Ability
of Elevated cAMP to Overcome Inhibition primed with BDNF (Compare Figures 6B and 6D with
Figure 7B). The putrescine effect is downstream ofby MAG and Myelin
Both Arg I and ornithine decarboxylase (ODC) are rate- cAMP/PKA because inclusion of a PKA inhibitor in the
assay has no effect on the ability of putrescine to over-limiting enzymes in the synthesis of polyamines from
arginine. A specific and potent inhibitor of Arg I is N come inhibition (Figure 7C). Similarly, there was no dif-
ference in neuronal survival when grown on myelin in(omega)-hydroxynor-L-arginine 5 (NOHA) (Boucher et
al., 1994) and of ornithine decarboxylate is DL-2-difluor- the presence or absence of putrescine; under both con-
ditions, about 80% of neurons survive (results notomethyl-ornithine (DFMO) (Slotkin et al., 1982), each of
Arg I, Polyamines in Regeneration on Myelin
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Figure 6. Blocking Polyamine Synthesis
Overcomes the cAMP Effect on Neurite Out-
growth on MAG and Myelin, and Putrescine
Restores It
Cerebellar neurons (P5) were isolated and
cultured on (A and B) MAG-expressing CHO
cells (stripped bars), control CHO cells (black
bars), or (C and D) myelin, and cultured over-
night before being fixed and stained for
GAP43. Where indicated, db cAMP (dbcA) (1
mM), DFMO (1 mM), or putrescine (40 M)
were added directly to the cocultures or when
being primed (24 hr) with BDNF (200 ng/ml).
In each experiment, the mean length of the
longest GAP43-positive neurite for 180–200
neurons was measured ( SEM) for at least
three separate experiments.
shown). Taken together, these results demonstrate that injury and general brain damage. We demonstrate here
that overexpression of Arg I or elevation of polyaminesputrescine alone can block the inhibition by MAG and
myelin. are each sufficient to overcome the inhibition of regener-
ation by MAG and myelin, a strong indication that similar
strategies can support regeneration in vivo. We alsoArginase I in DRG Neurons Is Downregulated with
Development that Coincides with the Switch show that upregulation of Arg I and synthesis of poly-
amines are triggered by elevated cAMP, which we andfrom Promotion to Inhibition by MAG and Myelin
Previously, we showed that dorsal root ganglion (DRG) others previously showed was sufficient not only to
overcome inhibition by MAG and myelin, but also forneurons switch their response to MAG and myelin with
age (DeBellard et al., 1996). Up to about postnatal day dorsal root spinal axons to regenerate in vivo and for
the regeneration of neonatal spinal axons (Cai et al.,(P)4, DRG neurons are promoted by MAG and will extend
neurites on myelin. Sharply at about P4, this response 2001; Qiu et al., 2002; Neumann et al., 2002). Consistent
with these results, Arg I levels are high in young DRGchanges, and DRG neurons older than P4 are inhibited
by MAG and will not extend neurites on myelin. We also neurons that are promoted by MAG and myelin. More-
over, if polyamine synthesis is blocked in young DRGshowed that this switch in response to MAG and myelin
is dictated by a spontaneous decrease in the endoge- neurons, so too is promotion. Conversely, in older DRG
neurons that are inhibited by MAG and myelin, Arg Inous neuronal levels of cAMP (Cai et al. 2001). Next we
showed that between P3 and P5, expression of Arg I levels are lower. Overexpression of Arg I in these neu-
rons neutralizes this inhibition. The decline in Arg I levelsprotein in DRG neurons drops spontaneously and pre-
cipitously by about 5-fold (Figure 8A). The level of Arg in DRG neurons with development parallels the decline
in endogenous cAMP levels we recorded before. To-I in DRG neurons remains at this low level through to
adult. Consistent with the higher levels of Arg I in young gether, these results provide insight into the molecular
downstream consequences of elevated cAMP that re-DRG neurons, the ability of P1 DRG neurons to grow
well on MAG is blocked by either the Arg I inhibitor, sults in regeneration. From the likely global effects of
elevated cAMP, we can now move to a more focusedNOHA, or the ODC inhibitor DFMO. Addition of putres-
cine to these young neurons had no effect on growth approach to encourage regeneration in vivo.
Arginase I has not been extensively characterized inon MAG cells or control cells (Figure 8B). Conversely,
overexpression of Arg I in P7 DRG neurons in which the nervous system. Liver and macrophages contain
both the cytosolic isoform Arg I and the mitochondrialendogenous levels are low overcomes inhibition by MAG
(Figure 8C). These results suggest that a drop in expres- isoform Arg II. Although each isoform is differentially
regulated, both are upregulated in response to cAMPsion of Arg I in DRG neurons is likely to be a consequence
of the spontaneous decrease in cAMP and contributes (Morris et al., 1998; Nebes and Morris, 1988). What is
particularly important is that Arg I has been shown toto the switch in the response of these neurons from
promotion to inhibition by MAG and myelin. be a neuronal anti-apoptotic factor (Esch et al., 1998).
Protein synthesis, required for apoptosis, is inhibited by
depleting neuronal arginine levels. Thus, upregulationDiscussion
or overexpression of Arg I in neurons of the damaged
nervous system would have two significant effects onThe ability to alter CNS axons intrinsically such that they
regenerate after injury in the adult would be a major neurons: preventing cell death and promoting regenera-
tion through an extracellular environment that is inhibi-advance in the development of therapies for spinal cord
Neuron
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Figure 8. Arg I Levels Dictate the Switch from Promotion to Inhibi-
tion by MAG of DRG Neurons during Development
(A) DRG neurons from P0 to P7 animals were isolated, lysed, sub-
jected to Western blotting, and immunostained for Arg I. Arrow
indicates Arg I protein.
(B and C) P0 (B) or P8 (C) DRG neurons were isolated and cultured
overnight on either MAG-expressing CHO cells (stripped bars) or
control CHO cells (black bars) before being fixed and stained for
Figure 7. Putrescine Alone Can Overcome Inhibition by MAG and GAP43. For the P0 DRGs (where indicated) DFMO (5 M), NOHA
Myelin in a Dose-Dependent Manner (0.5 mM), or putrescine (100 M) were included in the cultures. The
Cerebellar neurons (P5) were isolated and either primed overnight P8 DRG neurons were infected with either control virus (GFP) or
with various concentrations of putrescine (solid line), or putrescine virus-containing Arg I cDNA (Arg I) prior to coculture on the CHO
was added directly to the cocultures (nonprimed, broken line) of cells. In each experiment, the mean length of the longest GAP43-
neurons on MAG-expressing or control CHO cells (A) or on myelin positive (B) or GAP43/GFP-positive (C) neurite for 180–200 neurons
(B). The PKA inhibitor, KT5720 (200 nM), was included when priming was measured ( SEM) for at least three separate experiments.
with putrescine (100 M) before the neurons were grown on MAG-
expressing (stripped bars) or control (black bars, 0 CHO cells. In
each experiment, the mean length of the longest GAP43-positive
sole rate-limiting enzyme in the synthesis of polyaminesneurite for 180–200 neurons was measured ( SEM) for at least
from arginine, recent experiments have shown that Argthree separate experiments. Results are represented as percent of
control, which for (A) and (C) is control CHO cells and for (B), neurons I is also rate-limiting (Kepka-Lenhart et al., 2000) (Li et
grown on myelin in the absence of putrescine. al., 2001). In the experiments described here, Arg I does
indeed appear to be rate-limiting because of its effect
during development and because under these condi-
tions, there is no change in ODC expression with eithertory. Interestingly, cAMP by itself has also been shown
to be sufficient to promote survival of certain types of db cAMP or BDNF (results not shown). Second, putres-
cine both overcomes the block of Arg I and ODC inhibi-neurons (Hanson et al., 1998), as well as augmenting
the neurotrophin effects on others (Meyer-Franke et al., tion and alone can overcome inhibition by MAG/myelin
in a dose-dependent manner (Figures 6, 7, and 8). In-1995, 1998). We can speculate that these effects are
also mediated through an upregulation of Arg I. triguingly, putrescine’s effect in reversing inhibition is
enhanced with an overnight incubation before neuronsBased on our latest findings, we are extending our
hypothesis on the mechanism of action of cAMP in over- are cultured on MAG or myelin. The effect could be
due to the slow uptake of this highly charged moleculecoming inhibition and promoting regeneration (Cai et
al., 1999). We propose that a significant consequence across the plasma membrane; when added to cultures
at the same time as inhibitors, intracellular putrescineof Arg I upregulation by cAMP is the synthesis of poly-
amines. The observations that support this are: first, concentrations may be too low to achieve a maximal
effect. Alternatively, it is possible that polyamines triggerthat an inhibitor of either Arg I or ODC can block both
the db cAMP and the BDNF effect in overcoming inhibi- another round of transcription and that synthesis of an-
other unidentified protein(s) is required to overcome in-tion by MAG/myelin. Ornithine decarboxylase is directly
responsible for synthesis of putrescine from ornithine. hibition. The lag time for induction of new gene expres-
sion would require a longer period for maximum effectAlthough it was previously believed that ODC was the
Arg I, Polyamines in Regeneration on Myelin
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of putrescine on inhibition. At this point in our investiga- assembly by neutralizing the anionic C termini of tubulin,
tions, because putrescine is readily converted to so allowing the  and  monomers to come together
spermadine and then on to spermine, we do not know more readily. It is possible, then, that polyamines directly
if it is indeed putrescine or the subsequently synthesized affect the cytoskeleton to overcome inhibition. Further-
spermadine and spermine that is/are effecting the re- more, in the long-term (24–72 hr after treatment), poly-
generation. amines increase the expression of genes encoding the
Although polyamine synthesis is sufficient to block major cytoskeleton proteins (Kaminska et al., 1992). It is
inhibition, it is unlikely that it is the only pathway trig- conceivable that polyamines affect regeneration though
gered by elevated cAMP levels. Many pathways known both short and long term effects on the cytoskeleton.
to be activated by cAMP (Montminy, 1997) could be Finally, polyamines have been recently shown to affect
stimulated in parallel, with each contributing some mea- both inward rectifying potassium channels and gluta-
sure to overcoming inhibition. If this were the case, how- mate receptors in neurons (Chao et al., 1997; Kashiwagi
ever, each pathway would only be minimally activated, et al., 1997; Williams, 1997; Williams et al., 1994). Given
resulting in a threshold effect and overcoming inhibition the role of glutamate and its receptors in synaptic plas-
only when all pathways become active. Blocking any ticity (Abbott and Nelson, 2000; Gnegy, 2000), which
one pathway would diminish the total cAMP effect to also involves process outgrowth, it is reasonable to sus-
below threshold, and inhibition would not be overcome. pect that polyamines might overcome inhibition by
More reasonably, stimulating a single pathway maxi- MAG/myelin through a direct effect on these channels
mally would be sufficient alone to block inhibition by or receptors.
MAG/myelin, which is what we see for overexpression It is not known where polyamines exert their effect:
of ArgI/polyamines. inside or outside the neuron, at the cell body, or at the
Consistent with our observation that elevation of growth cone. We see an effect of polyamines after either
cAMP can overcome inhibition of MAG and myelin, oth- increasing their concentration through an overexpres-
ers have shown that cAMP can change the repulsion of sion of Arg I inside the neuron as well as when they are
growth cones by MAG and myelin in general (Song et added to culture media. Although polyamines are highly
al., 1998). In these assays, however, the effects are charged, they do cross the membrane in either direction.
acute, with a repulsive turning response to MAG and Moreover, polyamines have been shown to be trans-
myelin occurring within an hour. In this turning assay, ported down and to diffuse from the axon (Ingoglia et
elevation of cAMP reverses the repulsion to attraction al., 1982; Lindquist et al., 1985). Clearly, the possibility
in the same time frame. Given the short time required exists that polyamine effects emerge through a variety
to shift from repulsion to attraction, it is unlikely that of mechanisms, many of which may contribute to over-
this particular cAMP effect requires new transcription. coming inhibition.
Instead, activated PKA could be affecting the cytoskele- In summary, we have shown that elevation of cAMP
tal dynamics directly, resulting in more immediate ef- leads to an upregulation of Arg I and the synthesis of
fects. Further work will be needed to determine whether polyamines, which overcome inhibition of axonal regen-
the effect of cAMP on reversing growth cone turning eration by MAG and myelin. In addition, the spontaneous
and overcoming inhibition share mechanisms or are two growth of young neurons on MAG/myelin is also depen-
independent events. dent on this Arg I/polyamine mechanism. These results
Polyamines have been implicated in nervous system reveal not only a novel mechanism to overcome inhibi-
development, axonogenesis, and regeneration (Chu et al., tion, but also point to new and specific therapeutic strat-
1995; Dornay et al., 1986; Kauppila, 1992; Slotkin and egies to change the intrinsic ability of neurons to grow
Bartolome, 1986; Slotkin et al., 1982). The study presented through an inhibitory CNS environment and thereby en-
here extends that work significantly by demonstrating that courage regeneration in vivo.
polyamines can overcome inhibition, rather than just ac-
celerating regeneration, as previously suggested. The
Experimental Proceduresimportant question now is, how do polyamines bring
about this effect? Although there are numerous reports Neurite Outgrowth on Cells or Myelin
of polyamine influence in the nervous system, none have For myelin membranes (Norton and Poduslo, 1973), wells of an
pinpointed the mechanism behind their effects. In other eight-chamber tissue culture slide (Lab-Tek) were coated with 16.6
tissue, polyamines have been shown to affect a variety of g/ml poly L-lysine at room temperature for 1 hr. Rat CNS myelin
at 0.5–1.0 g total protein/well was dried overnight onto the coatedcell events (Cohen, 1998), including both DNA and protein
wells and used as a substrate (Mukhopadhyay et al., 1994; Shen etsynthesis. One possibility, then, is that polyamines may
al., 1998). Monolayers of control and MAG-expressing CHO cellstrigger a round of transcription to overcome inhibition
(Mukhopadhyay et al., 1994) were grown to confluency in individual
by MAG/myelin. Polyamines also are known to have both chambers of an eight-chamber tissue culture slide (Lab-Tek). Cere-
short- and long-term effects on the behavior of the cy- bellar and DRG neurons were isolated as described previously (De-
toskeleton. In studies on gastric mucosal healing, poly- Bellard et al., 1996). Where indicated neurons were plated on poly
amines directly affect the polymerization and organiza- L-lysine and primed overnight with BDNF (200 ng/ml) or putrescine
(10–100 mM) before being transferred to myelin or the CHO cells.tion of microtubules within hours of treatment (Banan
The neurite outgrowth assay was carried out as described previouslyet al., 1998). This in turn promotes cell migration, a nec-
(Mukhopadhyay et al., 1994) with the following modifications. 5 essary step in this healing process. This is supported
104 neurons were plated onto immobilized myelin and 2  104 neu-
by another report showing that polyamines have a signif- rons were used for the CHO cell monolayers. Where indicated, db
icant effect on the promotion of microtubule assembly cAMP (1 mM), DRB (5 M), DFMO (1–5 mM), NOHA (0.2–0.5 M),
from purified brain tubulin (Wolff, 1998). In these studies, putrescine (10–100 M), or BDNF (200 ng/ml) were added directly
to cultures or during priming. After 16–18 hr of incubation, the cul-the highly cationic polyamines are believed to promote
Neuron
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tures were fixed for 30 min with 4% paraformaldehyde, permeabil- GAP43. The longest neurite from 180–200 GFP/GAP43 double-posi-
tive neurons was measured.ized with ice-cold methanol, and immunostained with a rabbit poly-
clonal antibody against GAP43 (1:4000, from R. Curtis and G.
Wilkins, Imperial College, London) as previously described (Mukho- Acknowledgments
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Received: December 11, 2001overnight, using an RNeasy kit (Qiagen) following the manufacturers’
Revised: June 6, 2002instructions. cDNA was synthesized from total RNA using random
hexamers and reverse transcriptional enzyme (Stratagene) at 37C
for 2 hr. After which, Arg I cDNA was amplified using the following References
specific primers (Gibco BRL) that spanned nucleotide 197 to 700
of Arg I cDNA (Accession number NM017134): 5 GTC CCC AAT Abbott, L.F., and Nelson, S.B. (2000). Synaptic plasticity: taming the
GAC AGC CCC 3 and 5 CTT TTC TTC CTT CCC AGC AG 3 using beast. Nat. Neurosci. 3, 1178–1183.
the polymerase chain reaction (PCR) at 35 cycles These primers Abe, K., Chu, P., Shirahata, A., Samejima, K., and Saito, H. (1997).
were synthesized by GibcoBRL. Arg I cDNA was detected in a 1% Structural requirement for axonal regeneration-promoting effect of
agarose gel, stained with ethidium bromide. polyamines in cultured rat hippocampal neurons. Brain Res. 766,
281–284.
Immunodetection of Arg I Banan, A., McCormack, S.A., and Johnson, L.R. (1998). Polyamines
Cerebellar or DRG neurons of different ages were lysed in 50 mM are required for microtubule formation during gastric mucosal heal-
Tris-HCl (pH 7.4) containing 1% NP-40, 0.25% Na-deoxycholate, 1 ing. Am. J. Physiol. 274, G879–G885.
mM EDTA, 1 mM vanadate, and the following antiproteases: 1 g/
Bates, C.A., and Stelzner, D.J. (1993). Extension and regenerationml each of leupeptin, aprotinin, and pepstatin. The cell lysates were
of corticospinal axons after early spinal injury and the maintenancekept on ice for 15 min and centrifuged at 14,000  g for 10 min.
of corticospinal topography. Exp. Neurol. 123, 106–117.Protein concentration was measured in the supernatant with a Bio-
Boucher, J.L., Custot, J., Vadon, S., Delaforge, M., Lepoivre, M.,Rad kit (Bio-Rad Labs, Hercules, CA). Normalized lysates were
Tenu, J.P., Yapo, A., and Mansuy, D. (1994). N omega-hydroxyl-L-boiled for 5 min, after which they were subjected to SDS-PAGE in
arginine, an intermediate in the L-arginine to nitric oxide pathway,a 12% polyacrylamide gel, transferred to nitrocellulose membranes,
is a strong inhibitor of liver and macrophage arginase. Biochem.and immunostained with a rabbit polyclonal antibody against Arg
Biophys. Res. Commun. 203, 1614–1621.I (Esch et al., 1998) at 1:5000. Detection was with an enhanced
chemiluminescence (ECL) detection system, according to the manu- Bregman, B.S., and Goldberger, M.E. (1983). Infant lesion effect: III.
facturers’ instructions (Amersham). Anatomical correlates of sparing and recovery of function after spi-
nal cord damage in newborn and adult cats. Brain Res. 285, 137–154.
Measurement of Polyamine Cai, D., Shen, Y., De Bellard, M., Tang, S., and Filbin, M.T. (1999).
5  106 postnatal cerebellar neurons were plated onto poly L-lysine Prior exposure to neurotrophins blocks inhibition of axonal regener-
coated six-well plates. BDNF (200 ng/ml), dbcAMP (1 mM), or DFMO ation by MAG and myelin via a cAMP-dependent mechanism. Neu-
(1 mM) were added and incubated for various times as indicated. ron 22, 89–101.
Cells were washed and lysed in 100 l of 1.5 MHClO4. Three lysates Cai, D., Qiu, J., Cao, Z., McAtee, M., Bregman, B.S., and Filbin,
were pooled and the reaction was stopped by adding 150 l of M.T. (2001). Neuronal cyclic amp controls the developmental loss
neutralizing buffer (2 M potassium bicarbonate). After centrifuga- in ability of axons to regenerate. J. Neurosci. 21, 4731–4739.
tion, polyamines in the supernatant were measured by HPLC carried
Carbonetto, S., Evans, D., and Cochard, P. (1987). Nerve fiber growthout by a service (Dr. G. Wu, Department of Animal Science, Texas
in culture on tissue substrata from central and peripheral nervousA&M University).
systems. J. Neurosci. 7, 610–620.
Caroni, P., and Schwab, M.E. (1988). Two membrane protein frac-Cell Survival Assay
tions from rat central myelin with inhibitory properties for neuriteThe number of live and dead cells was estimated using a Live/Dead
growth and fibroblast spreading. J. Cell Biol. 106, 1281–1288.Viability/Cytotoxicity kit, according to the manufacturer’s instruc-
Chao, J., Seiler, N., Renault, J., Kashiwagi, K., Masuko, T., Igarashi,tions (Molecular Probes). Briefly, P5 cerebellar or P6–P8 DRG neu-
K., and Williams, K. (1997). N1-dansyl-spermine and N1-(n-octane-rons were plated at 50,000 cells per myelin-coated well of an eight-
sulfonyl)-spermine, novel glutamate receptor antagonists: block andchamber slide. The neurons were cultured overnight in the presence
permeation of N-methyl-D-aspartate receptors. Mol. Pharmacol. 51,or absence of BDNF (200 ng/ml) or putrescine (10 M or 50 M),
861–871.after which they were incubated with the vital dye Calcein AM and
ethidium homodimer-1. At least 200 neurons were scored for each Chen, M.S., Huber, A.B., van der Haar, M.E., Frank, M., Schnell, L.,
condition, and each experiment was carried out at least twice. Spillmann, A.A., Christ, F., and Schwab, M.E. (2000). Nogo-A is a
myelin-associated neurite outgrowth inhibitor and an antigen for
Adenoviral Infection of Neurons monoclonal antibody IN-1. Nature 403, 434–439.
Postnatal cerebellar neurons or DRG neurons of various ages as Chu, P.J., Saito, H., and Abe, K. (1995). Polyamines promote regen-
indicated and were plated on poly L-lysine-coated wells. Neurons eration of injured axons of cultured rat hippocampal neurons. Brain
were infected with recombinant adenovirus containing GFP cDNA Res. 673, 233–241.
(He et al., 1998) and Arg I cDNA or only GFP cDNA as control at a
Cohen, S. ed. (1998). A Guide to the Polyamines (New York: Oxford
final concentration of 108 PFU/ml. 1 hr after infection, media was
University Press).
changed and neurons were maintained for 1 day to recover and to
De Bellard, M., and Filbin, M.T. (1999). Myelin-associated glycopro-allow gene expression. Infected neurons were plated onto MAG-
tein, MAG, selectively binds several neuronal proteins. J. Neurosci.expressing cells, control CHO cells, or myelin substrate, and the
Res. 56, 213–218.neurite outgrowth assay was carried out as described above. After
overnight incubation, cultures were fixed and immunostained for DeBellard, M.E., Tang, S., Mukhopadhyay, G., Shen, Y.J., and Filbin,
Arg I, Polyamines in Regeneration on Myelin
719
M.T. (1996). Myelin-associated glycoprotein inhibits axonal regener- (1995). Characterization of the signaling interactions that promote
the survival and growth of developing retinal ganglion cells in cul-ation from a variety of neurons via interaction with a sialoglycopro-
tein. Mol. Cell. Neurosci. 7, 89–101. ture. Neuron 15, 805–819.
Meyer-Franke, A., Wilkinson, G.A., Kruttgen, A., Hu, M., Munro, E.,Domeniconi, M., Cao, Z., Spencer, T., Sivasankaran, R., Wang, K.C.,
Hanson, M.G., Jr., Reichardt, L.F., and Barres, B.A. (1998). Depolar-Nikulina, E., Kimura, N., Cai, H., Deng, K., Gao, Y., et al. (2002).
ization and cAMP elevation rapidly recruit TrkB to the plasma mem-Myelin-associated glycoprotein interacts with the Nogo66 receptor
brane of CNS neurons. Neuron 21, 681–693.to inhibit neurite outgrowth. Neuron 35, 283–290.
Montminy, M. (1997). Transcriptional regulation by cyclic AMP.Dornay, M., Gilad, V.H., Shiler, I., and Gilad, G.M. (1986). Early poly-
Annu. Rev. Biochem. 66, 807–822.amine treatment accelerates regeneration of rat sympathetic neu-
rons. Exp. Neurol. 92, 665–674. Morris, S.M., Jr., Kepka-Lenhart, D., and Chen, L.C. (1998). Differen-
tial regulation of arginases and inducible nitric oxide synthase inEsch, F., Lin, K.I., Hills, A., Zaman, K., Baraban, J.M., Chatterjee,
murine macrophage cells. Am. J. Physiol. 275, E740–E747.S., Rubin, L., Ash, D.E., and Ratan, R.R. (1998). Purification of a
multipotent antideath activity from bovine liver and its identification Mukhopadhyay, G., Doherty, P., Walsh, F.S., Crocker, P.R., and
as arginase: nitric oxide-independent inhibition of neuronal apopto- Filbin, M.T. (1994). A novel role for myelin-associated glycoprotein
sis. J. Neurosci. 18, 4083–4095. as an inhibitor of axonal regeneration. Neuron 13, 757–767.
Gilad, G.M., and Gilad, V.H. (1988). Early polyamine treatment en- Nakamura, H., Saheki, T., and Nakagawa, S. (1990). Differential cellu-
hances survival of sympathetic neurons after postnatal axonal injury lar localization of enzymes of L-arginine metabolism in the rat brain.
or immunosympathectomy. Brain Res. 466, 175–181. Brain Res. 530, 108–112.
Gilad, V.H., Tetzlaff, W.G., Rabey, J.M., and Gilad, G.M. (1996). Ac- Nebes, V.L., and Morris, S.M., Jr. (1988). Regulation of messenger
celerated recovery following polyamines and aminoguanidine treat- ribonucleic acid levels for five urea cycle enzymes in cultured rat
ment after facial nerve injury in rats. Brain Res. 724, 141–144. hepatocytes. Requirements for cyclic adenosine monophosphate,
glucocorticoids, and ongoing protein synthesis. Mol. Endocrinol. 2,Gnegy, M.E. (2000). Ca2/calmodulin signaling in NMDA-induced
444–451.synaptic plasticity. Crit. Rev. Neurobiol. 14, 91–129.
Neumann, S., Bradke, F., Tessier-Lavigne, M., and Basbaum, A.I.GrandPre, T., Nakamura, F., Vartanian, T., and Strittmatter, S.M.
(2002). Regeneration of sensory axons with the injured spinal cord(2000). Identification of the Nogo inhibitor of axon regeneration as
induced by intraganglionic cAMP elevation. Neuron 34, 885–893.a Reticulon protein, Nature 403, 439–444.
Norton, W.T., and Poduslo, S.E. (1973). Myelination in rat brain:Hanson, M.G., Jr., Shen, S., Wiemelt, A.P., McMorris, F.A., and Bar-
method of myelin isolation. J. Neurochem. 21, 749–757.res, B.A. (1998). Cyclic AMP elevation is sufficient to promote the
survival of spinal motor neurons in vitro. J. Neurosci. 18, 7361–7371. Prinjha, R., Moore, S.E., Vinson, M., Blake, S., Morrow, R., Christie,
G., Michalovich, D., Simmons, D.L., and Walsh, F.S. (2000). InhibitorHe, T.C., Zhou, S., da Costa, L.T., Yu, J., Kinzler, K.W., and Vo-
of neurite outgrowth in humans. Nature 403, 383–384.gelstein, B. (1998). A simplified system for generating recombinant
adenoviruses. Proc. Natl. Acad. Sci. USA 95, 2509–2514. Qiu, J., Cai, D., Dai, D., McAtee, M., Hoffman, P.N., Bregman, B.S.,
and Filbin, M.T. (2002). Spinal axon regeneration induced by eleva-Huang, D.W., McKerracher, L., Braun, P.E., and David, S. (1999). A
tion of cyclic AMP. Neuron 34, 895–903.therapeutic vaccine approach to stimulate axon regeneration in the
adult mammalian spinal cord. Neuron 24, 639–647. Schwab, M.E., and Bartholdi, D. (1996). Degeneration and regenera-
tion of axons in the lesioned spinal cord. Physiol. Rev. 76, 319–370.Ingoglia, N.A., Sharma, S.C., Pilchman, J., Baranowski, K., and Stur-
man, J.A. (1982). Axonal transport and transcellular transfer of nucle- Seiler, N. (2000). Oxidation of polyamines and brain injury. Neuro-
osides and polyamines in intact and regenerating optic nerves of chem. Res. 25, 471–490.
goldfish: speculation on the axonal regulation of periaxonal cell Shen, Y.J., DeBellard, M.E., Salzer, J.L., Roder, J., and Filbin, M.T.
metabolism. J. Neurosci. 2, 1412–1423. (1998). Myelin-associated glycoprotein in myelin and expressed by
Kaminska, B., Kaczmarek, L., and Grzelakowska-Sztabert, B. (1992). Schwann cells inhibits axonal regeneration and branching. Mol. Cell.
Inhibitors of polyamine biosynthesis affect the expression of genes Neurosci. 12, 79–91.
encoding cytoskeletal proteins. FEBS Lett. 304, 198–200. Slotkin, T.A., and Bartolome, J. (1986). Role of ornithine decarboxyl-
Kashiwagi, K., Pahk, A.J., Masuko, T., Igarashi, K., and Williams, K. ase and the polyamines in nervous system development: a review.
(1997). Block and modulation of N-methyl-D-aspartate receptors by Brain Res. Bull. 17, 307–320.
polyamines and protons: role of amino acid residues in the trans- Slotkin, T.A., Seidler, F.J., Trepanier, P.A., Whitmore, W.L., Lerea,
membrane and pore-forming regions of NR1 and NR2 subunits. Mol. L., Barnes, G.A., Weigel, S.J., and Bartolome, J. (1982). Ornithine
Pharmacol. 52, 701–713. decarboxylase and polyamines in tissues of the neonatal rat: effects
Kauppila, T. (1992). Polyamines enhance recovery after sciatic nerve of alpha-difluoromethylornithine, a specific, irreversible inhibitor of
trauma in the rat. Brain Res. 575, 299–303. ornithine decarboxylase. J. Pharmacol. Exp. Ther. 222, 741–745.
Kepka-Lenhart, D., Mistry, S.K., Wu, G., and Morris, S.M., Jr. (2000). Song, H., Ming, G., He, Z., Lehmann, M., McKerracher, L., Tessier-
Arginase I: a limiting factor for nitric oxide and polyamine synthesis Lavigne, M., and Poo, M. (1998). Conversion of neuronal growth
by activated macrophages? Am. J. Physiol. Regul. Integr. Comp. cone responses from repulsion to attraction by cyclic nucleotides.
Physiol. 279, R2237–R2242. Science 281, 1515–1518.
Li, H., Meininger, C.J., Kelly, K.A., Hawker, J.R., Jr., Morris, S.M., Wang, K.C., Koprivica, V., Kim, J.A., Sivasankaran, R., Guo, Y., Neve,
Jr., and Wu, G. (2001). Activities of arginase I and II are limiting for R.L., and He, Z. (2002). Oligodendrocyte-myelin glycoprotein is a
endothelial cell proliferation. Am. J. Physiol. Regul. Integr. Comp. Nogo receptor ligand that inhibits neurite outgrowth. Nature 417,
Physiol. 353, R245–R252. 941–944.
Lindquist, T.D., Sturman, J.A., Gould, R.M., and Ingoglia, N.A. (1985). Williams, K. (1997). Interactions of polyamines with ion channels.
Axonal transport of polyamines in intact and regenerating axons of Biochem. J. 325, 289–297.
the rat sciatic nerve. J. Neurochem. 44, 1913–1919. Williams, K., Zappia, A.M., Pritchett, D.B., Shen, Y.M., and Molinoff,
Liu, B.P., Fournier, A., Grandpre, T., and Strittmatter, S.M. (2002). P.B. (1994). Sensitivity of the N-methyl-D-aspartate receptor to poly-
Myelin-associated glycoprotein as a functional ligand for the amines is controlled by NR2 subunits. Mol. Pharmacol. 45, 803–809.
Nogo66 receptor. Science, in press. Wolff, J. (1998). Promotion of microtubule assembly by oligocations:
McKerracher, L., David, S., Jackson, D.L., Kottis, V., Dunn, R.J., and cooperativity between charged groups. Biochemistry 37, 10722–
Braun, P.E. (1994). Identification of myelin-associated glycoprotein 10729.
as a major myelin-derived inhibitor of neurite growth. Neuron 13,
805–811.
Meyer-Franke, A., Kaplan, M.R., Pfrieger, F.W., and Barres, B.A.
